Larisa Condurat
About Larisa Condurat
Larisa Condurat is an Affiliated Postdoctoral Scholar currently working at Harvard University and the Dana-Farber Cancer Institute, focusing on pediatric tumor research and targeted therapies. She earned her PhD in Cancer and Stem Cell Biology from the University of Freiburg and has extensive experience in cancer biology and oncolytic virotherapy.
Work at Broad Institute
Larisa Condurat has been affiliated with the Broad Institute of MIT and Harvard since 2018. In her role as an Affiliated Postdoctoral Scholar, she engages in advanced research focusing on cancer biology. The Broad Institute is known for its collaborative approach to biomedical research, and Condurat contributes to its mission of understanding the genetic basis of diseases.
Current Position at Dana-Farber Cancer Institute
Since 2018, Larisa Condurat has served as a Postdoctoral Research Fellow at the Dana-Farber Cancer Institute in the Greater Boston Area. Her research primarily focuses on pediatric tumors, where she characterizes pro-tumorigenic mechanisms. Dana-Farber is recognized for its commitment to cancer treatment and research, providing a platform for Condurat's work in developing targeted therapies.
Education and Expertise
Larisa Condurat earned her PhD in Cancer and Stem Cell Biology from The University of Freiburg, completing her studies from 2014 to 2018. Prior to her doctoral studies, she obtained a Master of Science in Cancer Biology and Oncolytic Virotherapy of Cancer from DKFZ German Cancer Research Center from 2011 to 2013. Additionally, she holds a Bachelor of Science in Experimental Biology from the University of Bucharest and has completed an Erasmus semester in Life Sciences and Cognitive Neurosciences at Université Denis Diderot (Paris VII).
Background and Early Career
Larisa Condurat began her career in research at DKFZ German Cancer Research Center, where she worked as a Student Assistant in Career Service from 2012 to 2013. This role provided her with foundational experience in the field of cancer research. Her academic journey includes a strong focus on cancer biology, which has shaped her current research interests in pediatric tumors.
Research Focus and Contributions
Condurat's research is centered on understanding pro-tumorigenic mechanisms in pediatric tumors. Since 2018, she has been actively involved in research activities in the Greater Boston Area, contributing to the development of targeted therapies for pediatric tumors. Her work aims to advance the understanding of cancer biology and improve treatment options for young patients.